-
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
-
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
-
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore
-
Self-collection Broadens Access to HPV ScreeningFDA approval allows patients to collect samples for HPV test, lowering a barrier to an important cancer prevention tool.
by Taneia Surles
-
To Understand Disparities, Look at the Broader ContextsResearchers at the AACR Annual Meeting 2024 consider ways in which social and economic factors like location affect cancer risk and outcomes.
by Eric Fitzsimmons
-
Cancer Care Does Not Move in Straight LinesCathy Nobil-Dutton did all the right things to protect her health, but a uterine cancer diagnosis showed her life doesn’t always go as expected.
by Cathy Nobil-Dutton
-
Regular Aspirin Use May Help Fight Colorectal CancerAspirin appears to activate an immune response against colorectal cancer in the early stages of the disease.
by Sandra Gordon
-
Progress Against CancerNew research fuels progress in cancer survival, prevention and side effect management.
-
Experts Urge Consideration Before Switching Cancer Care ProvidersPatients should consider the potential risks, and not just rewards, before changing providers.
by Kyle Bagenstose
-
Vaccines Spark Activity in Pancreatic CancerScientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.
by Thomas Celona
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
